Immunome discovers spike/nonspike SARS-CoV-2 antibodies

By The Science Advisory Board staff writers

February 18, 2021 -- Immunome has isolated potent antibodies that are capable of neutralizing several SARS-CoV-2 variants, including the South African variant (B.1.351), in pseudovirus testing.

The company discovered these antibodies by analyzing serum from SARS-CoV-2 "super-responders" who recovered from COVID-19 and mounted a robust immune response to a broad range of viral targets.

In July 2020, the company was awarded a $13.3 million technology award from the U.S. Department of Defense's Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) in collaboration with the Defense Health Agency.

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter